{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:10:31Z","timestamp":1782587431865,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T00:00:00Z","timestamp":1396396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.amjcard.2014.03.045","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T09:45:53Z","timestamp":1396431953000},"page":"2021-2029","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy, Safety, Tolerability, and Pharmacokinetic Profile of Evacetrapib Administered as Monotherapy or in Combination With Atorvastatin in Japanese Patients With Dyslipidemia"],"prefix":"10.1016","volume":"113","clinical-trial-number":[{"clinical-trial-number":"nct01375075","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Tamio","family":"Teramoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Ruotolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2014.03.045_bib1","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2014.03.045_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.amjcard.2013.08.041","article-title":"Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease","volume":"113","author":"Gotto","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.03.045_bib3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2013.05.012","article-title":"Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia","volume":"230","author":"Teramoto","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2014.03.045_bib4","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1194\/jlr.M018069","article-title":"Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure","volume":"52","author":"Cao","year":"2011","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.amjcard.2014.03.045_bib5","unstructured":"Nakano M, Morisaki Y, Friedrich S, James D, Nasu R, Takeuchi M, and Suico J.G. Safety, tolerability, and pharmacodynamics of evacetrapib in healthy Japanese. The 44th Annual Scientific Meeting of the Japan Atherosclerosis Society HS-30 p 206.\u00a02012."},{"key":"10.1016\/j.amjcard.2014.03.045_bib6","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2011.1649","article-title":"Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial","volume":"306","author":"Nicholls","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2014.03.045_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5551\/jat.E578","article-title":"Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese","volume":"14","author":"Teramoto","year":"2007","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.amjcard.2014.03.045_bib8","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1001\/jama.2011.1687","article-title":"High-density lipoprotein cholesterol as the Holy Grail","volume":"306","author":"Cannon","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2014.03.045_bib9","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1161\/CIRCULATIONAHA.108.790733","volume":"118","author":"Nicholls","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.03.045_bib10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa070635","article-title":"Effect of torcetrapib on the progression of coronary atherosclerosis","volume":"356","author":"Nissen","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2014.03.045_bib11","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/ATVBAHA.106.138347","article-title":"Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL","volume":"27","author":"Yvan-Charvet","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2014.03.045_bib12","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/ATVBAHA.110.207142","article-title":"Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib","volume":"30","author":"Yvan-Charvet","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2014.03.045_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.bbalip.2012.12.008","article-title":"Inhibition of cholesteryl ester transfer protein by anacetrapib does not impair the anti-inflammatory properties of high density lipoprotein","volume":"1831","author":"Han","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.amjcard.2014.03.045_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1752-8062.2011.00344.x","article-title":"CETP inhibitor torcetrapib promotes reverse cholesterol transport in obese insulin-resistant CETP-ApoB100 transgenic mice","volume":"4","author":"Briand","year":"2011","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.amjcard.2014.03.045_bib15","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1194\/jlr.M016410","article-title":"Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters","volume":"52","author":"Castro-Perez","year":"2011","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.amjcard.2014.03.045_bib16","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/psp.2013.70","article-title":"The pharmacokinetics and pharmacokinetic\/pharmacodynamic relationships of evacetrapib administered as monotherapy or in combination with statins","volume":"3","author":"Friedrich","year":"2014","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.amjcard.2014.03.045_bib17","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1009744","article-title":"Safety of anacetrapib in patients with or at high risk for coronary heart disease","volume":"363","author":"Cannon","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2014.03.045_bib18","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N\u00a0Engl J Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914914008881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914914008881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T01:54:20Z","timestamp":1538704460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914914008881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0002914914008881"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2014.03.045","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}